• About
  • Advertise
  • Privacy & Policy
  • Contact
HK Businesswire
  • Home
  • News
    • All
    • Business
    • Politics
    • PR Newswire
    • Science
    • World

    Akeso’s PD-1/CTLA-4 Bispecific Antibody Cadonilimab Approved for First-Line Treatment of Cervical Cancer in All-Comer Populations–Third Approved Indication for Cadonilimab

    Tiger Brokers Hong Kong Launches Inaugural Art Prize with HKBU AVA to Inspire Young Artists and Creative Crossovers

    Tiger Brokers Hong Kong Launches Inaugural Art Prize with HKBU AVA to Inspire Young Artists and Creative Crossovers

    JW Therapeutics Announces Approval of Relmacabtagene Autoleucel Injection (Carteyva®) for Marketing in Macao

    JW Therapeutics Announces Approval of Relmacabtagene Autoleucel Injection (Carteyva®) for Marketing in Macao

    Lockheed Martin Aims to Cultivate Filipino Talent, Stimulate Job Growth and Advance Local Defense Sector with Industrial Collaboration Proposal

    Lockheed Martin Aims to Cultivate Filipino Talent, Stimulate Job Growth and Advance Local Defense Sector with Industrial Collaboration Proposal

    NEXCOM Highlights Dual 5G Security Solutions and ODM Expertise at Interop Tokyo 2025

    NEXCOM Highlights Dual 5G Security Solutions and ODM Expertise at Interop Tokyo 2025

    Made to Create, Built to Grow — Wacom Introduces the New Wacom Cintiq Line

    Made to Create, Built to Grow — Wacom Introduces the New Wacom Cintiq Line

    Trending Tags

    • Trump Inauguration
    • United Stated
    • White House
    • Market Stories
    • Election Results
  • PR Newswire
  • Business
  • World
  • Entertainment
  • Sports
  • Tech
    • All
    • Apps
    • Gadget
    • Mobile
    • Startup

    CrowdStrike Shares Dip Despite Strong Q1 Earnings Amid Soft Revenue Guidance

    Constellation Energy (CEG) Stock Surges 37% in May 2025 Amid Strong Earnings and Strategic Partnerships

    Dunamu and HYBE’s NFT Platform ‘Momentica’ to Cease Operations Amid Ongoing Losses

    Shein Shifts IPO Plans to Hong Kong After London Listing Stalls

    Kingsoft Reports 9% Revenue Growth in Q1 2025 with Solid Gains in Office Software and Gaming

    Chinese firms double down on tech: Xiaomi, Haier

    Xiaomi Posts Record Q1 Results with Revenue Surpassing RMB 100 Billion and Net Profit Breaking RMB 10 Billion

    Trending Tags

    • Nintendo Switch
    • CES 2017
    • Playstation 4 Pro
    • Mark Zuckerberg
  • Feature
No Result
View All Result
  • Home
  • News
    • All
    • Business
    • Politics
    • PR Newswire
    • Science
    • World

    Akeso’s PD-1/CTLA-4 Bispecific Antibody Cadonilimab Approved for First-Line Treatment of Cervical Cancer in All-Comer Populations–Third Approved Indication for Cadonilimab

    Tiger Brokers Hong Kong Launches Inaugural Art Prize with HKBU AVA to Inspire Young Artists and Creative Crossovers

    Tiger Brokers Hong Kong Launches Inaugural Art Prize with HKBU AVA to Inspire Young Artists and Creative Crossovers

    JW Therapeutics Announces Approval of Relmacabtagene Autoleucel Injection (Carteyva®) for Marketing in Macao

    JW Therapeutics Announces Approval of Relmacabtagene Autoleucel Injection (Carteyva®) for Marketing in Macao

    Lockheed Martin Aims to Cultivate Filipino Talent, Stimulate Job Growth and Advance Local Defense Sector with Industrial Collaboration Proposal

    Lockheed Martin Aims to Cultivate Filipino Talent, Stimulate Job Growth and Advance Local Defense Sector with Industrial Collaboration Proposal

    NEXCOM Highlights Dual 5G Security Solutions and ODM Expertise at Interop Tokyo 2025

    NEXCOM Highlights Dual 5G Security Solutions and ODM Expertise at Interop Tokyo 2025

    Made to Create, Built to Grow — Wacom Introduces the New Wacom Cintiq Line

    Made to Create, Built to Grow — Wacom Introduces the New Wacom Cintiq Line

    Trending Tags

    • Trump Inauguration
    • United Stated
    • White House
    • Market Stories
    • Election Results
  • PR Newswire
  • Business
  • World
  • Entertainment
  • Sports
  • Tech
    • All
    • Apps
    • Gadget
    • Mobile
    • Startup

    CrowdStrike Shares Dip Despite Strong Q1 Earnings Amid Soft Revenue Guidance

    Constellation Energy (CEG) Stock Surges 37% in May 2025 Amid Strong Earnings and Strategic Partnerships

    Dunamu and HYBE’s NFT Platform ‘Momentica’ to Cease Operations Amid Ongoing Losses

    Shein Shifts IPO Plans to Hong Kong After London Listing Stalls

    Kingsoft Reports 9% Revenue Growth in Q1 2025 with Solid Gains in Office Software and Gaming

    Chinese firms double down on tech: Xiaomi, Haier

    Xiaomi Posts Record Q1 Results with Revenue Surpassing RMB 100 Billion and Net Profit Breaking RMB 10 Billion

    Trending Tags

    • Nintendo Switch
    • CES 2017
    • Playstation 4 Pro
    • Mark Zuckerberg
  • Feature
No Result
View All Result
HK Businesswire
No Result
View All Result
Home News PR Newswire

Kepler K2 “Bumblebee” Debuts at ICRA 2025, Captivating Attendees

PR Newswire by PR Newswire
3 June 2025
in PR Newswire
0
Kepler K2 “Bumblebee” Debuts at ICRA 2025, Captivating Attendees
0
SHARES
1
VIEWS
Share on FacebookShare on Twitter

ATLANTA, June 3, 2025 /PRNewswire/ — During the IEEE International Conference on Robotics and Automation 2025 (ICRA 2025) held in Atlanta from May 19 to 23, Shanghai Kepler Robotics Co., Ltd (“Kepler Humanoid Robot”) introduced its latest industrial-grade humanoid robot, the K2 “Bumblebee,” drawing global attention with a live demonstration of its real-world operational capabilities. The event brought together leading researchers, executives, and engineers from across the robotics ecosystem.


Notable visitors to the Kepler Humanoid Robot booth included Jim Fan, Senior Research Scientist at NVIDIA, and Hesheng Wang, General Chair of the International Conference on Intelligent Robots and Systems (IROS), among other robotics experts. They engaged in discussions on the trajectory of humanoid robotics and the path to scalable deployment in industrial environments.

Kepler’s booth quickly became a high-traffic destination at ICRA 2025. The K2 “Bumblebee” greeted attendees with natural gestures, navigated the venue with steady, autonomous mobility, and interacted fluidly with other robotic systems. Its engaging presence prompted a flurry of photos and videos, with many attendees lining up to pose with the robot.

Debo Hu, CEO of Kepler Humanoid Robot, stated, “The next major focus for the humanoid robot sector is achieving a complete commercial value loop, and industrial environments present the clearest path to near-term deployment. Our fifth-generation humanoid robots are now in limited-series production, with industrial use cases as our initial focus. Our latest round of funding reinforces our confidence in the commercial viability of our platform.”

Kepler Humanoid Robot is dedicated to developing industry-leading blue-collar humanoid systems. Purpose-built for industrial settings, the K2 “Bumblebee,” stands 175 cm tall, weighs 75 kg , and features 52 degrees of freedom and more than 80 integrated sensors. Its onboard compute reaches 100 TOPS, enabling it to autonomously execute task sequences in structured operational environments.

As the humanoid category moves into early-stage mass production, robots must demonstrate high payload capacity, endurance, and cost-efficiency to achieve sustainable deployment.

The K2 “Bumblebee” features Kepler’s proprietary planetary roller screw actuators, engineered for smooth motion control and reduced energy draw. With near-zero static power consumption, the robot offers extended uptime. Combined with its innovative series-parallel architecture and advanced actuation system, the K2 supports payloads of 15 kg per arm and up to 30 kg with both arms. The robot delivers up to 8 hours of operational time on a single 1-hour charge. Additionally, its proprietary rotary actuators enable millimeter-level precision for fine motor tasks.

In addition, the Kepler K2 “Bumblebee” also includes Kepler’s proprietary Dexterous Hands, each featuring 11 degrees of freedom, 25 force-sensing contact points per finger, and a 6-axis force/torque sensor at the wrist. These capabilities allow for advanced manipulation tasks across a range of industrial applications.

Kepler reports that over 80% of the robot’s core hardware is developed and manufactured in-house—supporting vertical integration, reducing costs, and improving supply chain resilience. The base model of the K2 “Bumblebee” is priced at $30,000 and can perform the equivalent workload of approximately 1.5 full-time human workers in comparable timeframes. 

Deployment flexibility is a key enabler for humanoid adoption. According to Goldman Sachs, humanoid robots are expected to begin integration into manufacturing environments between 2024 and 2027. Kepler is targeting intelligent manufacturing, warehousing and logistics, niche industries, academic research, and education as its primary markets. The company’s commercialization roadmap prioritizes penetration of specific verticals before expanding into general-purpose use cases.

K2 “Bumblebee” units are currently being trialed across a range of real-world industrial scenarios. Kepler continues to expand its partnerships throughout the robotics value chain to accelerate the transition from prototyping to commercial-scale deployment.

Tags: prnewswire
PR Newswire

PR Newswire

PR Newswire is the industry’s leading press release distribution partner with an unparalleled global reach of more than 440,000 newsrooms, websites, direct feeds, journalists and influencers and is available in more than 170 countries and 40 languages. From our award-winning Content Services offerings, integrated media newsroom and microsite products, Investor Relations suite of services, paid placement and social sharing tools, PR Newswire has a comprehensive catalog of solutions to solve the modern-day challenges PR and communications teams face. For 70 years, PR Newswire has been the preferred destination for brands to share their most important news stories across the world.

Read More

Akeso’s PD-1/CTLA-4 Bispecific Antibody Cadonilimab Approved for First-Line Treatment of Cervical Cancer in All-Comer Populations–Third Approved Indication for Cadonilimab

5 June 2025
Tiger Brokers Hong Kong Launches Inaugural Art Prize with HKBU AVA to Inspire Young Artists and Creative Crossovers

Tiger Brokers Hong Kong Launches Inaugural Art Prize with HKBU AVA to Inspire Young Artists and Creative Crossovers

5 June 2025
  • Trending
  • Comments
  • Latest

Power Talk | Cody OOH’s Hilda Cheung: Reinventing Hong Kong’s Moving Billboards for the AI Age

2 June 2025
Tunnel runs smoothly after takeover

Tunnel runs smoothly after takeover

31 May 2025
HKUST to research AI impact on business

HKUST to research AI impact on business

30 May 2025

Mixed responses to new tolls at Tai Lam Tunnel

2 June 2025

Akeso’s PD-1/CTLA-4 Bispecific Antibody Cadonilimab Approved for First-Line Treatment of Cervical Cancer in All-Comer Populations–Third Approved Indication for Cadonilimab

5 June 2025
Tiger Brokers Hong Kong Launches Inaugural Art Prize with HKBU AVA to Inspire Young Artists and Creative Crossovers

Tiger Brokers Hong Kong Launches Inaugural Art Prize with HKBU AVA to Inspire Young Artists and Creative Crossovers

5 June 2025
JW Therapeutics Announces Approval of Relmacabtagene Autoleucel Injection (Carteyva®) for Marketing in Macao

JW Therapeutics Announces Approval of Relmacabtagene Autoleucel Injection (Carteyva®) for Marketing in Macao

5 June 2025
Lockheed Martin Aims to Cultivate Filipino Talent, Stimulate Job Growth and Advance Local Defense Sector with Industrial Collaboration Proposal

Lockheed Martin Aims to Cultivate Filipino Talent, Stimulate Job Growth and Advance Local Defense Sector with Industrial Collaboration Proposal

5 June 2025

Recent News

Akeso’s PD-1/CTLA-4 Bispecific Antibody Cadonilimab Approved for First-Line Treatment of Cervical Cancer in All-Comer Populations–Third Approved Indication for Cadonilimab

5 June 2025
Tiger Brokers Hong Kong Launches Inaugural Art Prize with HKBU AVA to Inspire Young Artists and Creative Crossovers

Tiger Brokers Hong Kong Launches Inaugural Art Prize with HKBU AVA to Inspire Young Artists and Creative Crossovers

5 June 2025
JW Therapeutics Announces Approval of Relmacabtagene Autoleucel Injection (Carteyva®) for Marketing in Macao

JW Therapeutics Announces Approval of Relmacabtagene Autoleucel Injection (Carteyva®) for Marketing in Macao

5 June 2025
Lockheed Martin Aims to Cultivate Filipino Talent, Stimulate Job Growth and Advance Local Defense Sector with Industrial Collaboration Proposal

Lockheed Martin Aims to Cultivate Filipino Talent, Stimulate Job Growth and Advance Local Defense Sector with Industrial Collaboration Proposal

5 June 2025
HK Businesswire

Stay ahead with the latest insights on Hong Kong’s economy, finance, and investments. From market trends to policy updates, we bring you in-depth analysis and expert opinions.

📩 Subscribe to our newsletter for exclusive updates.
📍 Follow us on social media for real-time news.
📧 Contact us: info@hongkong-invest.com

Follow Us

  • About
  • Advertise
  • Privacy & Policy
  • Contact

© 2025 by HKBusinesswire.com

No Result
View All Result

© 2025 by HKBusinesswire.com